We found that decreased expression of CCND2 AS1 was associated with patient age and tumor size, and forced overexpression CCND2 AS1 inhibited cervical cancer cell proliferation in vitro and in vivo, at least partly by arresting the cells at the G1/S phase. Here, CCND2 is linked to cervical carcinoma.